protein

Biointron is proud to share that we have received the 2024 Scientist.com Supplier Performance Recognition Award, for our dedication to providing high-quality drug discovery research services on this industry-renowned R&D sourcing platform.

Antibody mimetics are engineered proteins that replicate antibody binding. Biointron explores their unique properties and potential advantages in therapy and research.

Autoimmune diseases demand precision therapy. Biointron explains how antibody drugs target RA, MS, and other conditions to reduce inflammation and improve outcomes.

Explore key highlights from PEGS 2024, featuring breakthroughs in antibody engineering, immunotherapy, ADC development, AI-driven discovery, and protein science.

Case 1: Tag-Free Vaccine Protein. During the generation of stable cell lines, cells are selected and screened to identify clones that stably express the protein of interest at desired levels. This case study illustrates the successful generation of a tag-free vaccine protein.